Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCohen Klingenstein LLC
Latest Disclosed Ownership47,559 shares
Latest Disclosed Value $ 2,884,453
Cohen Klingenstein LLC ownership in BRM / Bristol-Myers Squibb Company

On April 15, 2026 - Cohen Klingenstein LLC filed a 13F-HR form disclosing ownership of 47,559 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $2,493,043 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 47,559 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,255,723 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F Bristol-Myers Squibb COM 110122108 47,559 0 0.00 2,884 12.44 0.0934
2026-01-20 2025-12-31 13F Bristol-Myers Squibb COM 110122108 47,559 0 0.00 2,565 19.64 0.0779
2025-10-16 2025-09-30 13F Bristol-Myers Squibb COM 110122108 47,559 0 0.00 2,145 -2.59 0.0672
2025-07-18 2025-06-30 13F Bristol-Myers Squibb COM 110122108 47,559 0 0.00 2,202 -24.10 0.0735
2025-04-15 2025-03-31 13F Bristol-Myers Squibb COM 110122108 47,559 0 0.00 2,901 7.85 0.1051
2025-01-15 2024-12-31 13F Bristol-Myers Squibb COM 110122108 47,559 -21,000 -30.63 2,690 -24.19 0.0920
2024-10-16 2024-09-30 13F Bristol-Myers Squibb COM 110122108 68,559 -841 -1.21 3,547 23.07 0.1236
2024-07-15 2024-06-30 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 2,882 -23.41 0.1046
2024-04-12 2024-03-31 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 3,764 5.70 0.1401
2024-01-16 2023-12-31 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 3,561 -11.60 0.1456
2023-10-13 2023-09-30 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 4,028 -9.26 0.1824
2023-07-14 2023-06-30 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 4,438 -7.73 0.1922
2023-04-14 2023-03-31 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 4,810 -3.67 0.2259
2023-01-13 2022-12-31 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 4,993 1.20 0.2513
2022-10-12 2022-09-30 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 4,934 -7.67 0.2616
2022-07-15 2022-06-30 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 5,344 5.45 0.2680
2022-04-14 2022-03-31 13F Bristol-Myers Squibb COM 110122108 69,400 0 0.00 5,068 17.13 0.2105
2022-01-14 2021-12-31 13F Bristol-Myers Squibb COM 110122108 69,400 -13,654 -16.44 4,327 -11.95 0.1711
2021-10-15 2021-09-30 13F Bristol-Myers Squibb COM 110122108 83,054 -12,062 -12.68 4,914 -22.69 0.2148
2021-07-16 2021-06-30 13F Bristol-Myers Squibb COM 110122108 95,116 0 0.00 6,356 5.85 0.2732
2021-04-15 2021-03-31 13F Bristol-Myers Squibb COM 110122108 95,116 0 0.00 6,005 1.78 0.2770
2021-01-25 2020-12-31 13F/A-1 Bristol-Myers Squibb COM 110122108 95,116 0 0.00 5,900 2.88 0.2948
2021-01-19 2020-12-31 13F Bristol-Myers Squibb COM 110122108 95,116 0 5,900 294,654.0761
2020-10-19 2020-09-30 13F Bristol-Myers Squibb COM 110122108 95,116 0 0.00 5,735 2.54 0.3232
2020-07-15 2020-06-30 13F Bristol-Myers Squibb COM 110122108 95,116 0 0.00 5,593 5.49 0.3431
2020-04-15 2020-03-31 13F Bristol-Myers Squibb COM 110122108 95,116 0 0.00 5,302 -13.15 0.3922
2020-01-15 2019-12-31 13F Bristol-Myers Squibb COM 110122108 95,116 50,116 111.37 6,105 167.53 0.3546
2019-10-17 2019-09-30 13F Bristol-Myers Squibb COM 110122108 45,000 21,000 87.50 2,282 109.74 0.1434
2019-07-15 2019-06-30 13F Bristol-Myers Squibb COM 110122108 24,000 24,000 1,088 0.0775
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.